GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Gross Profit

Tci Gene (ROCO:6879) Gross Profit : NT$174.6 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Gross Profit?

Tci Gene's gross profit for the six months ended in Dec. 2023 was NT$96.9 Mil. Tci Gene's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was NT$174.6 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Tci Gene's gross profit for the six months ended in Dec. 2023 was NT$96.9 Mil. Tci Gene's Revenue for the six months ended in Dec. 2023 was NT$184.0 Mil. Therefore, Tci Gene's Gross Margin % for the quarter that ended in Dec. 2023 was 52.64%.

Tci Gene had a gross margin of 52.64% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 5 years, the highest Gross Margin % of Tci Gene was 70.21%. The lowest was 52.30%. And the median was 57.39%.


Tci Gene Gross Profit Historical Data

The historical data trend for Tci Gene's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Gross Profit Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
132.59 119.24 239.43 243.36 174.62

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only 156.87 143.72 99.64 77.77 96.85

Competitive Comparison of Tci Gene's Gross Profit

For the Biotechnology subindustry, Tci Gene's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tci Gene's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's Gross Profit distribution charts can be found below:

* The bar in red indicates where Tci Gene's Gross Profit falls into.



Tci Gene Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Tci Gene's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=333.855 - 159.238
=174.6

Tci Gene's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=183.992 - 87.142
=96.9

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$174.6 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Tci Gene's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=96.9 / 183.992
=52.64 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Tci Gene  (ROCO:6879) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Tci Gene had a gross margin of 52.64% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Tci Gene Gross Profit Related Terms

Thank you for viewing the detailed overview of Tci Gene's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Tci Gene (ROCO:6879) Business Description

Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines